| URL: | https://aocd.swmd.co.in |
| Full name: | Anti-obesity compound database |
| Description: | Anti-obesity compound database (AOCD) contains comprehensive information on all published small molecules from natural sources with anti-obesity potential targeting pancreatic lipase (PL), appetite suppressant (AS) and adipogenesis (AD). Presently the database contains 349 compounds isolated from 307 plants, 26 marine and 16 microbial sources. |
| Year founded: | 2022 |
| Last update: | |
| Version: | |
| Accessibility: |
Accessible
|
| Country/Region: | India |
| Data type: | |
| Data object: | |
| Database category: | |
| Major species: | |
| Keywords: |
| University/Institution: | Sri Ramachandra Institute of Higher Education and Research (DU) |
| Address: | |
| City: | |
| Province/State: | |
| Country/Region: | India |
| Contact name (PI/Team): | Dicky John Davis G |
| Contact email (PI/Helpdesk): | dicky@sriramachandra.edu.in |
|
Chemo-structural diversity of anti-obesity compound database. [PMID: 36702059]
Nature plays a major role in the development of new drugs which helps in preventing and treating human diseases. Anti-obesity compound database (AOCD) contains comprehensive information on all published small molecules from natural sources with anti-obesity potential targeting pancreatic lipase (PL), appetite suppressant (AS) and adipogenesis (AD). Presently the database contains 349 compounds isolated from 307 plants, 26 marine and 16 microbial sources. Users can query the AOCD database (https://aocd.swmd.co.in/) in several ways. The database was divided into three datasets (PL, AS and AD) to perform chemoinformatic analysis using Platform for Unified Molecular Analysis (PUMA), which were analyzed based on molecular descriptors, scaffold diversity and structural fingerprint diversity. Chemoinformatics study inferred the PL dataset has the highest diversity of compounds based on the Euclidean distance on molecular properties, scaffold diversity and pairwise similarity on fingerprint diversity. This study would hasten the process of anti-obesity drug discovery. |